gener
practition
stand
front
line
healthcar
provis
pivot
role
fight
increas
antibiot
resist
respect
target
antibiot
prescrib
gener
practition
would
help
reduc
unnecessari
use
antibiot
lead
reduc
treatment
failur
fewer
sideeffect
patient
reduct
global
spread
antibiot
resist
current
gold
standard
antibiot
resist
detect
strategi
tend
slow
take
h
obtain
result
although
implement
pointofcar
test
gener
practition
could
help
achiev
goal
target
antibiot
prescrib
practic
howev
decid
antibiot
resist
includ
pointofcar
diagnost
trivial
task
outlin
public
continu
spread
antibiot
resist
global
problem
predict
million
global
death
due
antibiot
resist
one
way
help
defeat
emerg
antibiot
resist
via
accur
prescrib
antibiot
patient
suffer
bacteri
instead
viral
infect
problem
accur
antibiot
prescrib
especi
relev
gener
practition
gp
gp
stand
front
line
patient
care
primari
care
often
first
point
contact
medic
specialist
gener
public
howev
rapid
differenti
bacteri
viral
infect
primari
care
patient
especi
difficult
achiev
sinc
patient
histori
physic
examin
limit
valu
differenti
viral
bacteri
infect
specimen
sent
central
diagnost
laboratori
tradit
gold
standard
test
result
pathogen
isol
identif
antibiot
resist
detect
may
take
sever
day
arriv
back
gp
practic
taken
togeth
mean
accur
evidencebas
diagnosi
target
antibiot
prescrib
gp
current
problemat
one
possibl
approach
problem
implement
call
pointofcar
poc
diagnost
gp
practic
mani
differ
poc
diagnost
current
avail
develop
detect
infecti
diseas
poc
diagnost
gener
divid
three
class
poc
diagnost
differenti
bacteri
viral
infect
without
defin
pathogen
present
exampl
diagnost
base
inflammatori
biomark
poc
diagnost
detect
report
specif
pathogen
may
present
case
bacteri
infect
provid
inform
presenc
antibiot
resist
exampl
diagnost
base
nucleic
acid
amplif
techniqu
poc
diagnost
detect
report
specif
pathogen
presenc
antibiot
resist
exampl
diagnost
base
nucleic
acid
amplif
techniqu
coupl
microarray
abil
accur
differenti
viral
bacteri
infect
may
help
enorm
reduc
amount
unnecessari
antibiot
prescrib
patient
suffer
viral
infect
may
tabl
potenti
problem
possibl
solut
choos
antibiot
resist
target
incorpor
pointofcar
diagnost
use
gener
practition
larg
divers
antibiot
resist
mechan
primari
care
develop
novel
poc
diagnost
detect
combin
hydrolyz
enzym
gene
mutat
event
downregul
efflux
pump
increas
loss
bacteri
porin
metabol
inact
bacteri
cell
poc
diagnost
innov
ensur
diagnost
built
around
flexibl
format
allow
rapid
easi
adapt
new
emerg
antibiot
resist
lack
knowledg
incid
antibiot
resist
gene
continu
epidemiolog
analysi
incid
specif
antibiot
resist
gene
within
primari
care
target
market
area
goal
could
achiev
ensur
connect
differ
poc
devic
within
singl
gp
practic
local
patient
inform
system
ultim
link
connect
poc
devic
within
local
geograph
region
could
gener
broader
includ
increas
region
data
gp
poc
develop
past
current
spread
futur
trend
antibiot
resist
within
target
region
chang
epidemiolog
antibiot
resist
due
traveland
ethnic
backgroundassoci
carriag
acquir
knowledg
regard
local
incid
antibiot
resist
potenti
effect
travelerassoci
colonizationinfect
prescrib
practic
local
gp
confound
influenc
impact
human
microbiota
develop
poc
diagnost
distinguish
antibiot
resist
present
pathogen
compar
nonpathogen
human
microbiota
obtain
detail
scientif
inform
specif
spread
antibiot
resist
nonpathogen
pathogen
order
provid
advic
whether
antibiot
resist
gene
nonpathogen
speci
like
spread
pathogen
speci
antibiot
treatment
inform
affect
antibiot
prescrib
practic
guidelin
lack
knowledg
nation
antibioticprescrib
guidelin
take
note
antibioticprescrib
guidelin
differ
countri
may
indic
currentfutur
resist
trend
awar
guidelin
may
chang
regularli
poc
diagnost
innov
ensur
poc
diagnost
flexibl
rapid
easi
adapt
chang
nation
antibioticprescrib
guidelin
molecular
phenotyp
analysi
possess
particular
advantag
disadvantag
awar
potenti
limit
associ
molecular
detect
antibiot
resist
gene
gene
promot
code
region
sequenc
may
provid
idea
express
specif
antibiot
resist
gene
mrna
proteinbas
diagnost
may
requir
note
even
mrna
protein
may
detect
dormant
antibiot
resist
gene
yet
expos
antibiot
develop
rapid
phenotyp
detect
test
would
act
catchal
techniqu
provid
simpl
answer
question
antibiot
resist
mani
antibiot
resist
mechan
mobil
genet
element
mutat
efflux
porin
etc
note
may
true
metabol
inact
antibiot
resist
microorgan
antibiot
resist
diagnost
actual
alter
gppatient
behavior
factor
influenc
prescrib
antibiot
eg
timetoresult
cost
ad
valu
etc
gp
need
better
understood
factor
poc
diagnost
develop
gp
gener
practition
poc
pointofcar
part
calcul
via
pocassist
measur
nonspecif
biomark
infect
exampl
creactiv
protein
crp
procalcitonin
pct
though
nonspecif
biomark
indic
bacteri
pathogen
resist
particular
antibiot
bacteri
infect
indic
detect
still
chanc
gp
may
prescrib
antibiot
suitabl
infect
due
lack
inform
possibl
express
antibiot
resist
caus
bacteri
pathogen
therefor
case
bacteri
infect
establish
could
potenti
use
gp
also
abl
determin
presenc
bacteri
viral
pathogen
also
presenc
antibiot
resist
practic
howev
actual
choic
feasibl
develop
antibiot
resist
detect
panel
use
poc
diagnost
primari
care
may
difficult
gener
appreci
poc
innov
microbiologist
gp
articl
author
highlight
major
challeng
barrier
current
exist
choos
antibiot
resist
target
use
poc
diagnost
gp
tabl
materi
present
base
discuss
took
place
part
eufund
diagora
project
wwwdiagoraseu
intend
develop
poc
diagnost
devic
use
gp
dentist
type
antibiot
resist
antibiot
resist
mechan
found
primari
care
set
depend
sever
factor
includ
avail
use
antibiot
gp
patient
within
particular
geograph
locat
commun
therefor
type
resist
detect
may
divers
includ
intrins
acquir
resist
intrins
resist
inher
characterist
microorgan
make
insensit
particular
antibiot
exampl
inher
resist
gramneg
microorgan
antibiot
vancomycin
due
inabl
vancomycin
effici
penetr
gramneg
bacteri
outer
membran
acquir
antimicrobi
resist
howev
relev
antimicrobi
prescrib
healthcar
gener
resist
previous
nonintrins
resist
antibiot
suscept
microorgan
resist
readili
transfer
differ
bacteri
speci
either
presenc
absenc
antibiot
transfer
antibiot
resist
gene
may
present
differ
mobil
genet
element
mge
carri
exampl
mani
differ
type
plasmid
via
conjug
transfer
uptak
nake
dna
transfect
spread
via
bacteriophagemedi
transfer
transduct
exampl
antimicrobi
resist
gene
carri
mge
includ
gene
code
antibiot
hydrolyz
protein
extend
spectrum
esbl
carbapenemas
exampl
klebsiella
pneumonia
carbapenemas
verona
integronencod
lactamas
etc
gene
may
mani
differ
variant
exampl
tem
isol
patient
temoneira
sulfhydryl
variant
shv
gene
variant
antibiot
resist
may
also
origin
via
nontransfer
genet
event
genet
mutat
exampl
mutat
quinolon
resistancedetermin
region
gyras
gyra
gene
may
result
bacteri
resist
quinolonebas
antibiot
ciprofloxacin
nalidix
acid
genet
mutat
may
also
associ
downregul
porin
upregul
efflux
pump
mani
differ
resist
mechan
may
present
within
singl
isol
bacterium
time
result
multiresist
even
panresist
microorgan
particular
respect
gener
practic
exampl
commun
respiratori
tract
infect
netherland
gener
treat
use
amoxicillin
second
third
choic
tetracyclin
macrolid
urinari
tract
infect
gener
treat
use
nitrofurantoin
phosphomycin
trimethoprim
ciprofloxacin
antibiot
resist
associ
combin
antibiot
includ
hyper
product
penicillinas
plasmid
resist
point
mutat
efflux
pump
etc
divers
antimicrobi
resist
mechan
mean
unlik
feasibl
develop
poc
diagnost
detect
differ
antibiot
resist
describ
scientif
literatur
instead
target
approach
may
requir
wherebi
diagnost
target
antimicrobi
resist
actual
circul
within
given
geograph
locat
commun
solut
howev
gener
two
problem
diagnost
innov
need
access
uptod
epidemiolog
data
antibiot
resist
target
healthcar
set
exist
novel
antimicrobi
resist
introduct
antimicrobi
resist
neighbor
geograph
locat
commun
may
miss
poc
diagnost
innov
includ
mani
ten
antibiot
resist
detect
panel
gp
knowledg
enough
signific
differ
resist
patient
relev
poc
diagnost
therefor
provid
advic
gp
depend
antibioticresist
result
give
advic
could
seen
advis
gp
treat
patient
rather
gp
make
decis
may
legal
ethic
implic
final
number
poc
diagnost
antibiot
resist
target
increas
price
diagnost
may
neg
affect
valu
cost
ratio
diagnost
gp
may
perhap
ask
need
buy
diagnost
detect
mani
differ
antibiot
resist
may
relev
geograph
locat
commun
incid
antibiot
resist
gene
may
vari
per
gp
geograph
locat
time
make
difficult
innov
predict
futur
trend
antibiot
resist
profil
exampl
resist
haemophilu
influenza
associ
respiratori
tract
infect
primari
care
previous
associ
carriag
express
transfer
gene
howev
appear
differ
carriag
canada
usa
mexico
scotland
turkey
said
like
antibiot
resist
phenotyp
associ
specif
diseas
particular
geograph
locat
commun
may
alreadi
known
gp
via
empir
experi
recent
treatment
success
failur
empir
knowledg
along
nation
guidelin
may
mean
antibiot
resist
test
seen
unnecessari
gp
addit
poc
diagnost
implement
determin
bacteri
futur
scienc
group
wwwfuturemedicinecom
identif
gp
may
alreadi
empir
awar
like
antibiot
resist
associ
particular
bacteri
pathogen
exampl
bacterium
moraxella
catarrhali
associ
upper
respiratori
tract
infect
otiti
media
children
lower
respiratori
tract
infect
exacerb
chronic
obstruct
pulmonari
diseas
adult
bacteri
pathogen
associ
carriag
singl
uniqu
enzym
present
one
two
slightli
differ
form
epidemiolog
studi
shown
penicillin
resist
carriag
bro
gene
approach
clinic
isol
mean
poc
diagnost
detect
bro
gene
may
actual
use
seen
financi
viabl
gp
especi
broadspectrum
altern
erythromycin
avail
prescript
cours
erythromycin
resist
clinic
isol
catarrhali
known
incid
resist
rel
low
region
world
possibl
influenc
rang
antibiot
resist
gene
seen
gp
within
hisher
practic
fact
travel
includ
holidaymak
sale
repres
etc
well
patient
undergo
surgeri
includ
elect
cosmet
surgeri
may
recent
visit
countri
high
preval
antibiot
resist
subsequ
becom
colon
nonloc
antibioticresist
bacteria
travel
exampl
nonloc
antibiot
resist
could
includ
variou
esbl
new
delhi
produc
bacteria
addit
commun
contain
rel
high
level
citizen
ethnic
minor
background
may
also
show
differ
rang
antibiot
resist
carri
question
poc
diagnost
innov
relev
traveland
ethnic
backgroundrel
antibiot
resist
patient
attend
gp
practic
differ
geograph
locat
unfortun
specif
collect
traveland
communitybas
antibiot
resist
data
like
expens
poc
diagnost
innov
import
also
rememb
gp
start
use
stronger
unusu
antibiot
pathogen
becom
resist
standard
antibiot
prescrib
within
gener
practic
cryptic
asymptomat
carriag
unusu
travelethn
backgroundassoci
antibiot
resist
within
commun
set
could
becom
import
scenario
vertic
transmiss
gene
relatedunrel
bacteri
speci
could
also
impact
risk
infect
pathogen
alreadi
resist
previous
use
antibiot
turn
could
mean
time
poc
develop
place
diagnost
healthcar
market
approxim
year
antibiot
resist
problem
may
chang
origin
data
detect
antibiot
resist
gene
within
clinic
sampl
automat
mean
caus
bacteri
pathogen
ill
actual
carri
resist
gene
detect
especi
true
transfer
gene
present
mge
ident
antibiot
resist
gene
wide
spread
within
bacteri
pathogen
also
within
normal
human
microbiota
patient
antibiot
resist
gene
found
present
clinic
sampl
clinician
sure
antibiot
resist
gene
present
within
bacteri
pathogen
actual
caus
diseas
present
harmless
member
patient
microbiota
focus
detect
mgeassoci
antibiot
resist
gene
may
partial
get
around
problem
associ
presenc
antibiot
resist
gene
within
human
microbiota
like
abl
transfer
pathogen
bacteria
addit
gp
may
take
note
recent
exposur
patient
antibiot
antibiot
resist
gener
previou
exposur
antibiot
could
persist
within
patient
human
microbiota
time
note
also
antibiot
resist
target
includ
poc
diagnost
chanc
detect
antibiot
resist
gene
normal
human
microbiota
includ
nonpathogen
microorgan
patient
also
increas
possibl
yield
fals
posit
result
least
respect
antibiot
sensit
actual
pathogen
mani
countri
produc
nation
guidelin
treatment
diseas
often
seen
within
primari
care
exampl
guidelin
includ
nation
institut
health
care
excel
nice
uk
nederland
huisartsen
genoostchap
nhg
netherland
essenti
poc
diagnost
innov
think
develop
antibiot
resist
diagnost
actual
take
note
guidelin
develop
test
antimicrobi
resist
base
antibioticprescrib
guidelin
countri
devic
sold
howev
poc
diagnost
innov
develop
differ
antibiot
resist
test
capac
specif
countri
may
make
financi
sens
unless
countri
standard
primari
care
guidelin
avail
larg
popul
access
primari
care
addit
nation
guidelin
antibiot
prescrib
regularli
revis
mean
poc
diagnost
innov
must
consid
time
requir
develop
market
gener
profit
new
antibiot
resist
test
fit
within
regular
cycl
nation
guidelin
revis
cours
revis
nation
guidelin
mean
say
actual
choic
antibiot
use
chang
poc
diagnost
innov
take
consider
weigh
time
poc
develop
market
final
gp
know
revis
antibioticprescrib
guidelin
due
month
may
less
inclin
buy
antibiot
resist
diagnost
may
date
within
month
one
possibl
solut
problem
poc
diagnost
innov
awar
problem
develop
diagnost
easili
quickli
adapt
rapidli
chang
ecosystem
inter
nation
guidelin
emerg
new
antibiot
resist
phenotyp
analysi
gold
standard
catchal
techniqu
determin
antibiot
resist
via
inabl
microorgan
replic
presenc
minimum
inhibitori
concentr
mic
antibiot
howev
current
problem
phenotyp
detect
includ
time
result
sensit
gener
need
central
laboratori
test
compar
nucleic
acid
amplif
techniqu
addit
major
current
avail
poc
infecti
diseas
diagnost
reli
nucleic
acidbas
amplif
usual
involv
polymeras
chain
reaction
pcr
isotherm
amplif
techniqu
detect
mgeassoci
antibiot
resist
gene
nucleic
amplif
techniqu
use
conserv
region
dna
target
highli
suit
detect
mani
transfer
antibiot
resist
gene
howev
antibiot
resist
occur
due
genet
mutat
less
easili
detect
use
standard
nucleic
acid
amplif
techniqu
mutat
mostli
occur
gene
normal
present
pathogen
bacterium
exampl
ciprofloxacin
resist
quinoloneresist
determin
region
detect
gene
per
se
provid
inform
actual
phenotyp
antibiot
resist
howev
poc
diagnost
detect
mutat
combin
gene
amplif
exampl
gene
amplif
follow
microarray
detect
gene
sequenc
may
distinct
advantag
gene
amplificationonli
poc
diagnost
respect
mutationassoci
antibiot
resist
essenti
gene
amplificationonli
diagnost
could
perceiv
offer
gp
enough
clinic
inform
antibiot
resist
caus
mutat
base
inform
antibioticprescrib
decis
could
serious
impact
perceiv
valu
nucleic
acid
amplificationonli
diagnost
devic
gp
final
anoth
unansw
question
whether
avail
poc
antibiot
resist
data
gp
actual
alter
antibioticprescrib
practic
gp
may
prescrib
antibiot
case
chanc
bacteri
infect
even
though
avail
poc
diagnost
alreadi
shown
presenc
viral
infect
reason
undetect
bacteri
superinfect
may
occur
top
viral
infect
anoth
potenti
unansw
question
gp
behav
antibioticprescrib
practic
poc
diagnost
devic
determin
exist
viral
bacteri
infect
gp
clinic
decisionmak
probabl
depend
patient
physic
examin
type
viru
influenza
viru
coronaviru
exampl
type
bacterium
detect
interestingli
howev
introduct
antibiot
resist
test
gp
may
help
persuad
patient
decis
prescrib
antibiot
ration
base
scientif
test
choos
use
antibiot
resist
gene
target
use
poc
diagnost
gener
practition
easi
task
current
choic
particularli
limit
divers
antibiot
resist
mechan
present
gener
practic
lack
epidemiolog
inform
origin
spread
antibiot
resist
mechan
within
particular
geograph
locat
within
particular
commun
limit
current
avail
poc
diagnost
technolog
rapidli
detect
mani
differ
type
antibiot
resist
mechan
known
lesser
problem
includ
inaccuraci
predict
futur
trend
antibiot
resist
lack
knowledg
impact
human
microbiota
antibiot
resist
carriag
antibiot
treatment
failur
futur
scienc
group
wwwfuturemedicinecom
note
even
challeng
success
overcom
success
failur
implement
futur
poc
antibiot
resist
diagnost
gener
practic
depend
mani
interact
factor
factor
includ
behavior
decisionmak
process
individu
gener
practition
timetoresult
perceiv
ad
valu
implement
poc
antibiot
resist
diagnost
gp
practic
gener
practition
first
line
defens
antibiot
resist
within
commun
better
target
antibiot
prescrib
exampl
use
pointofcar
poc
diagnost
could
potenti
help
reduc
amount
unnecessari
antibiot
prescrib
patient
choic
antibiot
resist
target
poc
diagnost
develop
current
problemat
antibiot
resist
mechan
gener
practic
divers
knowledg
incid
specif
antibiot
resist
mechan
requir
order
gener
guidelin
indic
specif
poc
diagnost
actual
clinic
relev
scientif
inform
may
requir
regard
specif
incid
antibiot
resist
nonpathogen
pathogen
poc
diagnost
innov
take
note
antibioticprescrib
guidelin
differ
countri
may
indic
futur
resist
trend
rang
incid
antibiot
resist
present
commun
could
affect
travel
holidaymak
andor
healthcar
migrant
exampl
patient
travel
abroad
cosmet
surgeri
procedur
ethnic
background
local
popul
awar
potenti
limit
associ
molecular
detect
antibiot
resist
gene
poc
diagnost
develop
rapid
phenotyp
detect
test
would
act
catchal
techniqu
provid
simpl
answer
question
antibiot
resist
antibiot
resist
mechan
public
support
eu
grant
grant
agreement
diagora
wwwdiagoraseu
